China NT Pharma Group Company Limited (HKG:1011)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
0.7400
+0.1400 (23.33%)
Jul 22, 2025, 4:08 PM HKT

HKG:1011 Ratios and Metrics

Millions HKD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 20202015 - 2019
Period Ending
Jul '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2015 - 2019
49971145171135229
Upgrade
Market Cap Growth
-36.20%-50.91%-15.27%26.76%-40.83%-27.27%
Upgrade
Enterprise Value
8894459931,0829921,420
Upgrade
Last Close Price
0.740.270.550.900.711.20
Upgrade
Forward PE
-15.3315.3315.3315.3315.33
Upgrade
PS Ratio
12.351.7717.90-0.490.87
Upgrade
PB Ratio
-1.17-0.17-0.39-0.63-0.528.58
Upgrade
P/FCF Ratio
--3.324.78-81.55
Upgrade
P/OCF Ratio
--2.614.19-7.34
Upgrade
EV/Sales Ratio
22.0011.01122.42-3.575.39
Upgrade
EV/FCF Ratio
-90.35-22.6930.19-506.69
Upgrade
Debt / Equity Ratio
-0.94-0.94-1.02-3.42-3.9437.97
Upgrade
Debt / FCF Ratio
--8.6826.06-360.79
Upgrade
Asset Turnover
0.110.110.01-0.200.14
Upgrade
Inventory Turnover
----2.742.81
Upgrade
Quick Ratio
0.010.010.020.050.050.35
Upgrade
Current Ratio
0.020.020.020.060.300.50
Upgrade
Return on Equity (ROE)
------307.64%
Upgrade
Return on Assets (ROA)
-2.49%-2.49%-5.26%-1.69%-5.19%-2.95%
Upgrade
Return on Capital (ROIC)
---11.91%-2.75%-7.82%-4.56%
Upgrade
Earnings Yield
-11.38%-79.63%-108.91%-43.79%-135.74%-185.81%
Upgrade
FCF Yield
-1.97%-13.80%30.14%20.92%-123.43%1.23%
Upgrade
Buyback Yield / Dilution
-27.18%-10.72%-25.59%-0.51%-0.14%-6.98%
Upgrade
Total Shareholder Return
--10.72%-25.59%-0.51%-0.14%-6.98%
Upgrade
Source: S&P Global Market Intelligence. Standard template. Financial Sources.